Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 86
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Respir Res ; 25(1): 207, 2024 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-38750572

RESUMEN

BACKGROUND: The evidence regarding effects of statins on exacerbation risk in COPD remains controversial. Previous studies often excluded patients with cardiovascular comorbidities despite their high prevalence in COPD and role for exacerbations. Based on the cardioprotective properties of statins, we hypothesised that statins may reduce the risk of exacerbations especially in patients with cardiovascular comorbidities. METHODS: One thousand eight hundred eighty seven patients of the German COPD cohort COSYCONET (COPD and Systemic Consequences Comorbidities Network) of GOLD grades 1-4 (37.8% female, mean age 64.78 ± 8.3) were examined at baseline and over a period of 4.5 years for the occurrence of at least one exacerbation or severe exacerbation per year in cross-sectional and longitudinal analyses adjusted for age, gender, BMI, GOLD grade and pack-years. Due to their collinearity, various cardiovascular diseases were tested in separate analyses, whereby the potential effect of statins in the presence of a specific comorbidity was tested as interaction between statins and comorbidity. We also identified patients who never took statins, always took statins, or initiated statin intake during the follow-up. RESULTS: One thousand three hundred six patients never took statins, 31.6% were statin user, and 12.9% initiated statins during the follow-up. Most cardiovascular diseases were significantly (p < 0.05)may associated with an increased risk of COPD exacerbations, but in none of them the intake of statins was a significant attenuating factor, neither overall nor in modulating the increased risk linked to the specific comorbidities. The results of the cross-sectional and longitudinal analyses were consistent with each other, also those regarding at least 1 exacerbation or at least 1 severe exacerbation per year. CONCLUSION: These findings complement the existing literature and may suggest that even in patients with COPD, cardiovascular comorbidities and a statin therapy that targets these comorbidities, the effects of statins on exacerbation risk are either negligible or more subtle than a reduction in exacerbation frequency. TRIAL REGISTRATION: Trial registration ClinicalTrials.gov, Identifier: NCT01245933. Other Study ID (BMBF grant): 01GI0881, registered 18 November 2010, study start 2010-11, primary completion 2013-12, study completion 2023-09. https://clinicaltrials.gov/study/NCT01245933?cond=COPD&term=COSYCONET&rank=3.


Asunto(s)
Enfermedades Cardiovasculares , Comorbilidad , Inhibidores de Hidroximetilglutaril-CoA Reductasas , Enfermedad Pulmonar Obstructiva Crónica , Humanos , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Femenino , Masculino , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Persona de Mediana Edad , Anciano , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/tratamiento farmacológico , Enfermedades Cardiovasculares/prevención & control , Estudios Transversales , Estudios de Cohortes , Estudios Longitudinales , Progresión de la Enfermedad , Alemania/epidemiología , Estudios de Seguimiento
2.
Respir Res ; 25(1): 56, 2024 Jan 24.
Artículo en Inglés | MEDLINE | ID: mdl-38267944

RESUMEN

BACKGROUND: MRproANP and COPAVP are prognostic markers for mortality in chronic obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict mortality due to cardiovascular diseases, which are important prognostically determining comorbidities in patients with COPD. However, less is known about these biomarkers in recently diagnosed mild to moderate COPD. Therefore, we analyzed these biomarkers as potential predictors of mortality in recently diagnosed mild to moderate COPD. METHODS: The blood biomarkers considered were copeptin (COPAVP), midregional adrenomedullin (MRproADM), midregional proatrial naturetic peptide (MRproANP), and fibrinogen. Analyses were performed in patients with stable "recently diagnosed mild to moderate COPD" defined by GOLD grades 0-2 and diagnosis of COPD ≤ 5 years prior to inclusion into the COSYCONET cohort (COPD and Systemic Consequences-Comorbidities Network), using Cox regression analysis with stepwise adjustment for multiple COPD characteristics, comorbidities, troponin and NT-proBNP. RESULTS: 655 patients with recently diagnosed mild to moderate COPD were included. In the initial regression model, 43 of 655 patients died during the 6-year follow-up, in the final model 27 of 487. Regression analyses with adjustment for confounders identified COPAVP and MRproANP as statistically robust biomarkers (p < 0.05 each) of all-cause mortality, while MRproADM and fibrinogen were not. The fourth quartile of MRproANP (97 pmol/L) was associated with a hazard ratio of 4.5 (95%CI: 1.6; 12.8), and the fourth quartile of COPAVP (9.2 pmol/L) with 3.0 (1.1; 8.0). The results for MRproANP were confirmed in the total cohort of grade 0-4 (n = 1470 finally). CONCLUSION: In patients with recently diagnosed mild to moderate COPD, elevated values of COPVP and in particular MRproANP were robust, independent biomarkers for all-cause mortality risk after adjustment for multiple other factors. This suggests that these markers might be considered in the risk assessment of early COPD.


Asunto(s)
Enfermedades Cardiovasculares , Glicopéptidos , Enfermedad Pulmonar Obstructiva Crónica , Humanos , Biomarcadores , Fibrinógeno , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico
3.
Allergol Immunopathol (Madr) ; 47(4): 386-400, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30797627

RESUMEN

BACKGROUND: Asthma is the most common chronic disease in children, and associations with crowding have been reported. The aim of this study was to explore possible associations of crowding with asthma in children. METHODS: Seven cross-sectional surveys with preschool children were conducted within the framework of the health monitoring units in Bavaria, Germany, from 2004 to 2014. Residential crowding was defined as habitation of more than one person per room or less than 20m2 living space per person. Logistic regression models examined temporal changes in crowding, applying the first survey as reference. The relationship between crowding and physician-diagnosed asthma, asthma defined by the International Study of Asthma and Allergies in Childhood (ISAAC) and asthma symptoms were analyzed. RESULTS: Analyzing temporal changes of crowding rates did not reveal any differences over the years. However, the stratified descriptive analysis indicated a crowding increase in time in urban households where parents had a low education level (47.9% in 2004/05, 55.8% in 2014/15). No association was found between crowding and the variables "physician-diagnosed asthma" in 2014/15, "asthma defined by ISAAC" in 2014/15, or "wheezing" in 2014/15. A positive association with cough was identified in 2014/15 after adjusting for confounders (aOR=1.42 [95% CI: 1.20-1.69]). CONCLUSIONS: In general, residential crowding did not change from 2004 to 2014; however, there seems to be a small upsurge for children with low-educated parents, living in urban areas over the years. A statistically significant association between crowding and cough was only found in the survey from 2014/15.


Asunto(s)
Asma/epidemiología , Aglomeración , Condiciones Sociales/estadística & datos numéricos , Población Urbana , Niño , Preescolar , Estudios Transversales , Femenino , Alemania/epidemiología , Humanos , Masculino , Encuestas y Cuestionarios
4.
Arch Gynecol Obstet ; 300(5): 1303-1316, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31531777

RESUMEN

PURPOSE: The impact of colonization with antimicrobial-resistant bacteria (AMRB) and methicillin-sensitive Staphylococcus aureus (MSSA) of healthy pregnant women is not described in detail in Germany. In this study, we screened for MSSA and AMRB, especially for methicillin-resistant S. aureus (MRSA) as well as extended-spectrum beta-lactamase (ESBL)-producing E. coli. Potential risk factors for colonization with AMRB/MSSA and the potential effects of colonization with these on the obstetric population were investigated. METHODS: From October 2013 until December 2015 pregnant women were screened before birth for colonization with AMRB/MSSA from the mammillae, nose, perianal and vaginal area. Before birth, the expectant mother was administered a standardized interview questionnaire by a trained interviewer. Data from the hospital admission records were also included. RESULTS: Samples from 651 pregnant women were analyzed. Colonization with MSSA was detected in 14.3% (n = 93), AMRB in 3.5% [(n = 23); MRSA: n = 3/ESBL: n = 20]. Significantly more colonization of AMRB/MSSA could be detected in women who had previously given birth compared to women who were nulliparous (p < 0.05). MSSA colonization was significantly associated with self-reported respiratory diseases during pregnancy (p < 0.05), but AMRB/MSSA colonization was not statistically associated with other types of infection. CONCLUSION: Our results demonstrate a low overall rate of colonization with AMRB/MSSA, as well as a low percentage of colonized pregnant women who developed infections. Multiparous women are at higher risk for colonization with MSSA/MRSA or ESBL. Because the prevalence of AMRB/MSSA is low, this study suggests that general screening of pregnant women without risk factors is not recommended.


Asunto(s)
Antibacterianos/uso terapéutico , Staphylococcus aureus/patogenicidad , Adulto , Antibacterianos/farmacología , Estudios Transversales , Femenino , Humanos , Staphylococcus aureus Resistente a Meticilina , Embarazo , Prevalencia , Factores de Riesgo , Infecciones Estafilocócicas
5.
Occup Med (Lond) ; 69(3): 195-203, 2019 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-30882860

RESUMEN

BACKGROUND: Health promotion in the workplace is intended to enhance employee health and well-being. Yoga programmes are easy to implement and have been effective in the management of various health conditions. AIMS: To assess the evidence regarding the effectiveness of yoga programmes at work. METHODS: A search of electronic databases of published studies up until the 1st of April 2017. Inclusion criteria for the systematic review were randomized controlled trials of adult employees and yoga in the workplace. Quality appraisal was carried out using the Cochrane Collaboration's tool for assessing risk of bias in randomized trials. RESULTS: Of 1343 papers identified, 13 studies met the inclusion criteria. Nine out of 13 trials were classified as having an unclear risk of bias. The overall effects of yoga on mental health outcomes were beneficial, mainly on stress. Most of the cardiovascular endpoints showed no differences between yoga and controls. Other outcomes reported positive effects of yoga or no change. CONCLUSIONS: The findings of this study suggest that yoga has a positive effect on health in the workplace, particularly in reducing stress, and no negative effects were reported in any of the randomized controlled trials. Further larger studies are required to confirm this.


Asunto(s)
Promoción de la Salud , Salud Laboral , Lugar de Trabajo/psicología , Yoga , Humanos , Evaluación de Programas y Proyectos de Salud , Calidad de Vida
6.
Eur J Clin Microbiol Infect Dis ; 36(10): 1819-1826, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28474179

RESUMEN

Up to now, little has been known about the prevalence and clinical relevance of colonisation of asymptomatic pregnant women with methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA) or extended-spectrum ß-lactamase (ESBL)-producing Escherichia coli. In this two-centre cross-sectional study, we evaluated the performance and importance of screening at different times and different locations for colonisation in pregnant women and newborns. Between October 2013 and December 2015, four samples were collected from pregnant women, two from newborns at birth and three from 3-day-old newborns. Samples were screened on culturing media and were confirmed with molecular methods. MSSA was used as a surrogate for MRSA, as the two share most microbiologic characteristics and colonisation patterns. Of 763 pregnant women, 14.5% (111) were colonised with MSSA, 0.4% (3) with MRSA and 2.6% (20) with ESBL-producing E. coli. Of 658 newborns, 0.9% (10) were colonised with MSSA at birth and 13.1% (70) at 3 days old, 0.5% (3) were colonised with MRSA and 2.6% (17) with ESBL-producing E. coli. Nasal sampling identified 91.0% of MSSA-colonised pregnant women and 60.0% of newborns. In newborns, nasal and umbilical sampling at 3 days after birth discovered 84.0% of colonised cases. For ESBL-producing E. coli, the perianal region was positive in all colonised pregnant women and in 88.2% of colonised newborns. Combining nasal and perianal swabs is optimal when screening for antibiotic-resistant bacteria in pregnant women. Nasal, perianal and umbilical sample collection from 3-day-old newborns significantly increased the sensitivity compared to screening immediately after birth.


Asunto(s)
Infecciones Bacterianas/diagnóstico , Portador Sano/diagnóstico , Farmacorresistencia Bacteriana , Escherichia coli/aislamiento & purificación , Manejo de Especímenes/métodos , Staphylococcus aureus/aislamiento & purificación , Adolescente , Adulto , Infecciones Bacterianas/epidemiología , Infecciones Bacterianas/microbiología , Portador Sano/epidemiología , Portador Sano/microbiología , Estudios Transversales , Escherichia coli/efectos de los fármacos , Femenino , Humanos , Recién Nacido , Masculino , Embarazo , Complicaciones Infecciosas del Embarazo , Staphylococcus aureus/efectos de los fármacos , Encuestas y Cuestionarios , Adulto Joven
7.
Gesundheitswesen ; 79(4): e39-e49, 2017 Apr.
Artículo en Alemán | MEDLINE | ID: mdl-27097312

RESUMEN

Background and Objectives: Exposure to recreational noise is becoming increasingly important due to a change in leisure behavior amongst children and adolescents. The aim of this pilot study was to assess exposure of 6th grade pupils to recreational noise from portable listening devices (PLD). Furthermore, preventive measures to reduce recreational noise exposure should be identified. Methods: In "Ohrkan Kids", 38 Bavarian pupils aged 11 to 14 were interviewed regarding their music listening behavior using a standardized questionnaire. In addition, measurements of commonly used volume settings on the children's portable listening devices were carried out. Furthermore, the German Social Accident Insurance (DGUV), health insurance companies as well as health and education ministries of the German federal states were surveyed regarding their activities in the prevention of recreational noise exposure. Results: Based on the questionnaire data for weekly usage, 10 out of 31 children (32.3%) exceeded the upper exposure value of 85 dB recommended by labor protection law. Taking actually measured values, 9 out of 31 children (29%) exceeded this level. The DGUV and some federal states carry out specific projects for the prevention of recreational noise exposure. Conclusion: The large number of children with hazardous music consumption indicates that measures for the prevention of noise-induced hearing loss are already required for 11 to 14 year olds. To maximize the number of children addressed, age-appropriate and target-group-specific preventive measures are needed. As there are only few studies which examined the effectiveness of awareness campaigns for the prevention of recreational noise, any future prevention projects should be evaluated with an increased focus on estimating their effectiveness.


Asunto(s)
Exposición a Riesgos Ambientales/prevención & control , Exposición a Riesgos Ambientales/estadística & datos numéricos , Pérdida Auditiva/epidemiología , Pérdida Auditiva/prevención & control , Ruido/efectos adversos , Recreación , Estudiantes/estadística & datos numéricos , Adolescente , Niño , Exposición a Riesgos Ambientales/análisis , Femenino , Alemania/epidemiología , Humanos , Masculino , Música , Proyectos Piloto , Prevalencia , Factores de Riesgo
8.
Gesundheitswesen ; 78(4): 200-2, 2016 Apr.
Artículo en Alemán | MEDLINE | ID: mdl-27078829

RESUMEN

Employees and volunteers often feel insecure about the potential transmission of infectious diseases when taking care of asylum seekers. It could be shown that overall only a minor risk of infection emanates from asylum seekers. However, aspects of occupational health and vaccination should be kept in mind.Besides the standard vaccination the Standing Committee on Vaccination (STIKO) recommends for occupational indication, which is given for employees and volunteers in asylum facilities, vaccination against hepatitis A, hepatitis B, polio (if the last vaccination was more than 10 years before) as well as influenza (seasonal).According to the German Occupational Safety and Health Act taking care of the employer has to determine which exposures might occur at the workplace (risk assessment) and define necessary protection measures. Depending on task and exposure when taking care of asylum seekers different acts (e. g. biological agents regulation) and technical guidelines for the handling biological agents (e. g. TRBA 250 or TRBA 500) have to be applied.The Bavarian Health and Food Safety Authority (LGL) has published several information sheets regarding "asylum seekers and health management" for employees and volunteers from the non-medical as well as the medical area (www.lgl.bayern.de search term "Asylbewerber"). With theses publications insecurities in taking care of asylum seekers should be prevented. Furthermore the employer gets support in the implementation of legal obligations to ensure occupational safety for the employees.


Asunto(s)
Accesibilidad a los Servicios de Salud/organización & administración , Programas de Inmunización/organización & administración , Medicina del Trabajo/organización & administración , Práctica de Salud Pública , Refugiados , Virosis/prevención & control , Alemania , Humanos , Modelos Organizacionales , Salud Laboral/estadística & datos numéricos , Vacunas Virales/administración & dosificación
9.
Am J Physiol Lung Cell Mol Physiol ; 309(6): L605-13, 2015 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-26209273

RESUMEN

Microorganisms have an important role in tumorgenesis by the induction of inflammation and by a direct impact on tumor cells. Chronic obstructive pulmonary disease (COPD) is associated with an increased risk for lung cancer and microbial colonization. We asked whether bacterial pathogens act as tumor promoters during CS-induced pulmonary inflammation. In a metastatic lung cancer (LC) model, Lewis lung carcinoma (LLC) cells were injected in mice to initiate the growth of tumors in the lung. Exposure to the combination of cigarette smoke (CS) and nontypeable Haemophilus influenzae (NTHi) synergistically increased metastatic growth. Lung levels of albumin and LDH, translocation of bacterial factors into tumor tissue, tumor inflammation, and tumor proliferation were significantly increased in mice exposed to CS in combination with NTHi. Bacterial pathogens increased the proliferation of cultured LLC cells and human cancer cell lines. Metastatic growth induced by the exposure to CS in combination with NTHi was reduced in mice deficient for IL-17. Our data provide evidence that CS-induced loss of pulmonary barrier integrity allows bacterial factors to translocate into tumor tissue and to regulate tumor-associated inflammation and tumor proliferation. Translocation of bacterial factors in tumor tissue links CS-induced inflammation with tumor proliferation.


Asunto(s)
Carcinoma Pulmonar de Lewis/inmunología , Neoplasias Pulmonares/inmunología , Fumar/efectos adversos , Animales , Traslocación Bacteriana , Carcinoma Pulmonar de Lewis/microbiología , Carcinoma Pulmonar de Lewis/secundario , Línea Celular Tumoral , Proliferación Celular , Femenino , Humanos , Neoplasias Pulmonares/microbiología , Neoplasias Pulmonares/patología , Ratones Endogámicos C57BL , Trasplante de Neoplasias , Carga Tumoral
10.
Artículo en Alemán | MEDLINE | ID: mdl-25367175

RESUMEN

Hygiene is becoming more and more important in long-term care facilities. Long-term care facilities are subject to monitoring by the Public Health Service (PHS) and other authorities. For the PHS in Bavaria the Bavarian Health and Food Safety Authority (Landesamt für Gesundheit und Lebensmittelsicherheit, LGL) published a hygiene monitoring concept and there exists an inspection guide developed by a specialist department for nursing homes and institutions for the handicapped (Fachstelle für Pflege und Behinderteneinrichtungen, FQA). Because inspections are performed in multiprofessional teams, it makes sense to use a coordinated inspection catalog. The aim was to integrate hygienic requirements specified in the Bavarian guidelines for hygiene by the LGL into the inspection guide published by the FQA to obtain a quality assured surveillance. The involved parties were questioned about the inspection guide and their hygiene management and then the hygiene criteria of the LGL were implemented into the inspection guide. Questions dealing with hygiene requirements concerning intensive care, management of multidrug resistant bacteria and interviews with the person responsible for infection control in the facility itself were developed for the first time and were integrated into the inspection guide. The revised inspection guide was tested for its applicability. With the revised inspection guide there now exists a tool which allows not only comprehensive inspections of the facilities including hygiene issues but also a good cooperation of the various parties involved. There are many actions which have to be conveyed into the future, especially programs to train staff to apply the inspection guide and to enhance the ability of all participants to act in cooperation. The guide will also allow the facilities to cooperate more easily and more closely, as the guide takes the respective problems and challenges of the different facilities into consideration. Additionally the development of legal guidelines regarding hygiene can support general healthcare of residents.


Asunto(s)
Infección Hospitalaria/prevención & control , Higiene/normas , Cuidados a Largo Plazo/normas , Casas de Salud/normas , Guías de Práctica Clínica como Asunto , Garantía de la Calidad de Atención de Salud/normas , Alemania , Humanos , Manuales como Asunto/normas
12.
Gesundheitswesen ; 75(2): 111-8, 2013 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-22615025

RESUMEN

BACKGROUND: Surveillance of infection control management and practices in home care is an important task of the public health service. While infection control aspects in residential homes for the aged and nursing are increasingly being discussed this subject has been poorly recognised in home care. AIM: The aim of this study was to identify problems in hygiene regarding the transmission of infectious diseases as well as quality assessment in home care. Based on the results of this study implications for infection control in home care facilities for public health services should be developed. METHOD: Statistical analyses were performed on the primary quality assessment data of home care facilities collected by the medical service of health insurances via computer-assisted personal interviews between March 2006 and March 2009. Structure quality in 194 home care facilities was analysed as well as human resources and organisational conditions. Analyses were also done in the context of the clients' risk factor load. All analyses were performed by stratifying for the size of the home care services. To assess how the involved characteristics vary according to the size of the home care services chi-square tests and non-parametric tests were calculated. RESULTS: About 80% of the assessed home care services disposed of an infection control management plan. Compared to larger services smaller home care services, especially services with less than 10 clients had a poor structure in infection control management and practice. They also carried a higher load of risk factors in clients. The larger services had significantly less human resources. CONCLUSIONS: Surveillance of infection control management and practices by the public health services should focus on the structure of the smaller home care services. At the same time smaller home care services should be supported by offering training for the staff or counselling regarding hygiene-related aspects. Furthermore, the outcome quality of the larger home care services with poorer human resources (one full-time nurse cares for more than 10 dependants) should also be assessed in the frame of infection surveillance.


Asunto(s)
Servicios de Atención de Salud a Domicilio/organización & administración , Servicios de Atención de Salud a Domicilio/estadística & datos numéricos , Higiene , Control de Infecciones/organización & administración , Control de Infecciones/estadística & datos numéricos , Evaluación de Programas y Proyectos de Salud , Alemania , Humanos
13.
Sci Rep ; 13(1): 21568, 2023 12 07.
Artículo en Inglés | MEDLINE | ID: mdl-38057347

RESUMEN

It has been shown that pollen information services are an important self-management tool for patients with pollen-related allergic rhinitis (AR) and allergic asthma (AA). This study aimed to design an online application for patients with AR and AA, which supports patients to better manage their disease as well as to evaluate the app and present the first results of the pilot study. The pollen data were obtained from the electronic pollen information network of Bavaria, Germany. Participants were asked to fill in their allergy-related complaints in the app over a 60-day period. Subsequently, the app was evaluated. Indices and diagrams visualized the participants' individual complaints as well as the daily pollen concentration in the air. In order to motivate participants to complete the app on a daily basis, we used elements of gamification. Two thirds of the participants (N = 46) reported feeling better informed about pollen counts and their allergy when using the app. The app's simple and comprehensible design was rated positively. More than 80% of the participants would recommend the app to their family and friends. The app can be a tool for patients with AR and AA to better understand their disease.


Asunto(s)
Asma , Aplicaciones Móviles , Rinitis Alérgica Estacional , Rinitis Alérgica , Automanejo , Humanos , Rinitis Alérgica Estacional/terapia , Proyectos Piloto , Rinitis Alérgica/terapia , Polen , Asma/terapia , Alérgenos
14.
Gesundheitswesen ; 74(10): 653-60, 2012 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-22566165

RESUMEN

BACKGROUND: Multidrugresistant pathogens which are highly relevant for infection control in hospitals and other health-care facilities are a serious public health problem and a big challenge for all players in the health sector. In order to prevent the spread of multi-resistant pathogens the Commission for Hospital Hygiene of the Robert Koch-Institute (RKI) has published guidelines. These recommendations refer to the consequent implementation of an infection control management in all health care settings, including outpatient care. In Germany there are only few data available concerning infection control management and the implementation of preventive strategies in outpatient care. SUBJECT: To what extent are national guidelines concerning infection control of multidrugresistant pathogens (i.e. methicillin-resistant Staphylococcus aureus, MRSA) feasible and practicable in outpatient care? And what are the reasons not to practice these strategies. METHOD: In outpatient care the status of the infection control management and the implementation of prevention strategies was surveyed and assessed. Data were collected by structured interviews - a face to face method. RESULT: Guidelines concerning infection control management are not always sufficiently implemented in outpatient care. There are multiple reasons for this, such as, e.g., lack of compliance with the recommendations as well as structural problems in the health-care system, and special challenges of outpatient care. CONCLUSION: Implementation of an infection control management concerning multidrug-resistant pathogens in outpatient care is problematic. Prevention strategies are commonly not known or not adequately implemented into daily practice. Actions to improve the situation should focus at the individual level (e.g., trainings in the context of the initiative "clean hands" ), the institutional level (improving networking, bonus schemes) and the social level (financial and legal support for outpatient care centres to bear the expenses of infection control management, "search and destroy").


Asunto(s)
Infecciones Bacterianas/prevención & control , Infecciones Bacterianas/transmisión , Control de Enfermedades Transmisibles/organización & administración , Control de Enfermedades Transmisibles/normas , Infección Hospitalaria/prevención & control , Infección Hospitalaria/transmisión , Farmacorresistencia Bacteriana Múltiple , Servicios de Atención de Salud a Domicilio , Hogares para Ancianos , Casas de Salud , Infecciones Bacterianas/microbiología , Lista de Verificación , Control de Enfermedades Transmisibles/economía , Infección Hospitalaria/microbiología , Estudios de Factibilidad , Apoyo Financiero , Alemania , Adhesión a Directriz , Desinfección de las Manos/economía , Encuestas de Atención de la Salud , Humanos , Capacitación en Servicio/economía , Staphylococcus aureus Resistente a Meticilina , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/prevención & control , Infecciones Estafilocócicas/transmisión , Encuestas y Cuestionarios
15.
Artículo en Alemán | MEDLINE | ID: mdl-23114445

RESUMEN

Rehabilitation facilities often apply the same standards for management of methicillin-resistant Staphylococcus aureus (MRSA) carriers as acute care hospitals. This makes it difficult to ensure access to the facilities and adequate rehabilitation for carriers. A working group of the Bavarian state committee for multiresistant pathogens addressed these problems by a systematic review of literature, expert group meetings and evaluation of existing hygiene plans. Thereby a model hygiene plan for rehabilitation facilities concerning management of MRSA carriers was derived. The management is based on physician risk assessment blending standards applied in acute and long-term care facilities. For rehabilitation typical risk scenario examples of risk analyses are given. The preventive measures are based on the respective objectives of protection. The risk analysis which gives the basis for the model hygiene plan described in this paper gives equal weight to two main objectives of protection: infection control and medical rehabilitation.


Asunto(s)
Control de Enfermedades Transmisibles/métodos , Control de Enfermedades Transmisibles/normas , Infección Hospitalaria/microbiología , Infección Hospitalaria/prevención & control , Higiene , Staphylococcus aureus Resistente a Meticilina , Centros de Rehabilitación/normas , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/prevención & control , Portador Sano/microbiología , Portador Sano/prevención & control , Infección Hospitalaria/transmisión , Reservorios de Enfermedades , Alemania , Desinfección de las Manos/normas , Humanos , Cuidados a Largo Plazo , Tamizaje Masivo/organización & administración , Tamizaje Masivo/normas , Gestión de Riesgos/métodos , Gestión de Riesgos/normas , Infecciones Estafilocócicas/transmisión
17.
Eur Respir J ; 35(2): 343-52, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19679599

RESUMEN

The pulmonary innate immune system in the respiratory tract eliminates inhaled pathogens. Several cell types contribute to host defense within a complex network. The aim of this study was to evaluate the role of macrophages during pneumonia and in the regulation of the epithelial response to microorganisms. We performed lung infection models in mice lacking myeloid RelA/p65. To study the mechanistic relationships between individual cell types, we applied co-culture models composed of airway epithelial cells (AECs) and macrophages. Mice lacking myeloid RelA/p65 showed significantly decreased bacterial clearance, cytokine expression and neutrophil influx. In addition, the induction of epithelial keratinocyte chemoattractant expression was blunted in these animals. In vitro, AECs were largely insensitive to ligands of Toll-like receptor (TLR)2 or TLR5. Exposure to secretory products of macrophages results in an increased release of pro-inflammatory cytokines and augmented antimicrobial activity. This was associated with increased expression of TLR genes and surface expression of the proteins. Experiments with blocking antibodies showed that the effect of macrophages depends on secreted mediators, including tumour necrosis factor-alpha. In conclusion, the present data show that myeloid RelA is critical for pulmonary host defense. One important mechanism is that macrophages induce the sensitivity of AEC's to microbial patterns.


Asunto(s)
Pulmón/inmunología , Células Mieloides/metabolismo , Factor de Transcripción ReIA/metabolismo , Animales , Péptidos Catiónicos Antimicrobianos/química , Asma/inmunología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Células Epiteliales/inmunología , Citometría de Flujo , Pulmón/metabolismo , Macrófagos/metabolismo , Ratones , Neutrófilos/metabolismo , Enfermedad Pulmonar Obstructiva Crónica/inmunología , Receptores Toll-Like/metabolismo
18.
Eur Respir J ; 35(5): 960-8, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20436173

RESUMEN

alpha(1)-Antitrypsin (AT) deficiency is a hereditary disorder that may lead to early-onset emphysema, and chronic liver disease later in life. Although there are validated methods for testing, the vast majority of alpha(1)-AT-deficient individuals remain undiagnosed. Recommendations have been published for the testing and diagnosis of alpha( 1)-AT deficiency; however, guidelines on best practice are not well established. In our article, we review the developments in diagnostic techniques that have taken place in recent years, and describe the practices used in our three European centres. The determination of the level of alpha(1)-AT and genotyping are reported as the main diagnostic steps, whereas isoelectric focusing (also referred to as phenotyping) is reserved for confirmatory analysis. The following recommendations for best practice are put forward: detection of all PiZZ and other severe deficiency individuals; automated genotyping; preparation of reference standards; quality control programmes; development of standard operating procedure documents; and standardised methods for the collection of dried blood samples. Closer cooperation between laboratories and the sharing of knowledge are recommended, with the objectives of improving the efficiency of the diagnosis of severe alpha(1)-AT deficiency, increasing the numbers of individuals who are detected with the disorder, and assisting the establishment of new patient identification programmes.


Asunto(s)
Pruebas Genéticas/métodos , Hepatopatías/sangre , Enfisema Pulmonar/sangre , Deficiencia de alfa 1-Antitripsina/sangre , Algoritmos , Recolección de Muestras de Sangre , Enfermedad Crónica , Alemania/epidemiología , Humanos , Focalización Isoeléctrica , Italia/epidemiología , Hepatopatías/epidemiología , Hepatopatías/genética , Fenotipo , Guías de Práctica Clínica como Asunto , Enfisema Pulmonar/epidemiología , Enfisema Pulmonar/genética , España/epidemiología , alfa 1-Antitripsina/sangre , alfa 1-Antitripsina/genética , Deficiencia de alfa 1-Antitripsina/epidemiología , Deficiencia de alfa 1-Antitripsina/genética
19.
Sci Rep ; 10(1): 10544, 2020 06 29.
Artículo en Inglés | MEDLINE | ID: mdl-32601330

RESUMEN

We studied whether in patients with stable COPD blood gases (BG), especially oxygenated hemoglobin (OxyHem) as a novel biomarker confer information on disease burden and prognosis and how this adds to the information provided by the comorbidity pattern and systemic inflammation. Data from 2137 patients (GOLD grades 1-4) of the baseline dataset of the COSYCONET COPD cohort were used. The associations with dyspnea, exacerbation history, BODE-Index (cut-off ≤2) and all-cause mortality over 3 years of follow-up were determined by logistic and Cox regression analyses, with sex, age, BMI and pack years as covariates. Predictive values were evaluated by ROC curves. Capillary blood gases included SaO2, PaO2, PaCO2, pH, BE and the concentration of OxyHem [haemoglobin (Hb) x fractional SaO2, g/dL] as a simple-to-measure correlate of oxygen content. Inflammatory markers were WBC, CRP, IL-6 and -8, TNF-alpha and fibrinogen, and comorbidities comprised a broad panel including cardiac and metabolic disorders. Among BG, OxyHem was associated with dyspnoea, exacerbation history, BODE-Index and mortality. Among inflammatory markers and comorbidities, only WBC and heart failure were consistently related to all outcomes. ROC analyses indicated that OxyHem provided information of a magnitude comparable to that of WBC, with optimal cut-off values of 12.5 g/dL and 8000/µL, respectively. Regarding mortality, OxyHem also carried independent, additional information, showing a hazard ratio of 2.77 (95% CI: 1.85-4.15, p < 0.0001) for values <12.5 g/dL. For comparison, the hazard ratio for WBC > 8000/µL was 2.33 (95% CI: 1.60-3.39, p < 0.0001). In stable COPD, the concentration of oxygenated hemoglobin provided additional information on disease state, especially mortality risk. OxyHem can be calculated from hemoglobin concentration and oxygen saturation without the need for the measurement of PaO2. It thus appears well suited for clinical use with minimal equipment, especially for GPs.


Asunto(s)
Oxihemoglobinas/metabolismo , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Análisis de los Gases de la Sangre , Femenino , Humanos , Inflamación/sangre , Masculino , Persona de Mediana Edad , Pronóstico , Enfermedad Pulmonar Obstructiva Crónica/sangre , Enfermedad Pulmonar Obstructiva Crónica/mortalidad , Índice de Severidad de la Enfermedad , Tasa de Supervivencia
20.
Thorax ; 64(2): 144-9, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18852155

RESUMEN

BACKGROUND: Smoking increases the susceptibility to pulmonary infection and is a risk factor for the development of chronic obstructive pulmonary disease (COPD). It is postulated that cigarette smoke suppresses the activation of the innate immune system in response to bacterial infection. METHODS: Using sensitive ex vivo analysis, the level of the endogenous antibiotic peptide human beta-defensin-2 (hBD-2) was measured in pharyngeal washing fluid and sputum from patients with community acquired pneumonia. The regulation of antibacterial host defence molecules was studied in vitro. The effect of cigarette smoke on the antibacterial activity of differentiated airway epithelium and the expression of host defence molecules was studied in an in vitro infection model. RESULTS: Current or former smoking was associated with significantly reduced hBD-2 levels in pharyngeal washing fluid and sputum from patients with acute pneumonia. Exposure of airway epithelium to smoke in vitro inhibited the induction of hBD-2 by bacteria. This correlated with decreased antimicrobial activity. This effect was mimicked by hydrogen peroxide, and catalase blunted the smoke-induced inhibition of epithelial host defence. CONCLUSIONS: Smoke exposure suppresses the induction of epithelial antibacterial host defences. These findings link smoking with increased susceptibility to infection. This mechanism may be important in the pathogenesis of pneumonia and COPD.


Asunto(s)
Infecciones Comunitarias Adquiridas/inmunología , Inmunidad Innata/inmunología , Neumonía Bacteriana/inmunología , Fumar/inmunología , beta-Defensinas/metabolismo , Ensayo de Inmunoadsorción Enzimática , Células Epiteliales/inmunología , Células Epiteliales/microbiología , Femenino , Humanos , Peróxido de Hidrógeno/farmacología , Tolerancia Inmunológica/inmunología , Inmunidad Mucosa/inmunología , Masculino , Persona de Mediana Edad , Oxidantes/farmacología , Faringe/química , Infecciones por Pseudomonas/inmunología , Pseudomonas aeruginosa/inmunología , Pseudomonas aeruginosa/aislamiento & purificación , Esputo/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA